Earnings Preview For Vanda Pharma
Portfolio Pulse from Benzinga Insights
Vanda Pharma (NASDAQ:VNDA) is scheduled to release its quarterly earnings report on February 7, 2024, with analysts expecting an EPS of $-0.09. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat leading to a 21.94% drop. Shares are currently trading at $3.47, down 47.48% over the last year. Investors are looking for positive guidance for the next quarter.
February 06, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vanda Pharma is expected to report an EPS of $-0.09 for the upcoming quarter. Historical data shows significant stock price movements post-earnings, with a notable 21.94% drop after last quarter's beat.
Given VNDA's mixed historical earnings performance and the current analyst expectations, the short-term impact on VNDA's stock price is uncertain. The company's guidance for the next quarter will likely play a crucial role in influencing investor sentiment and stock price movement. The recent trend of stock price decline post-earnings, despite beating estimates, adds to the unpredictability.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100